MDT — Medtronic plc.
Is MDT overbought or oversold? Here is the current MarketMoodz read.
Medtronic plc. (MDT) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Medical Devices) last closed at $83.19. The rating moved from Oversold to Overbought on July 3, 2026 and has changed 30 times in the last 90 days.
- Public ratingOverbought (as of July 5, 2026)
- Last close$83.19
- Rating changesRating changed 30 times in the last 90 days
- Last changeMoved from Oversold to Overbought on July 3, 2026
- SectorHealthcare
- IndustryMedical Devices
Latest MarketMoodz coverage
- BTIG Upgrades Medtronic to Buy; Stock Trades at Valuation Discount2026-06-04
- Tempus AI Stock Rises on ALERT Trial Boost for AI EHR2026-04-01
- GlucoTrack stock rises as data backs FDA filing plans for implantable CGM2026-03-27
- Medtronic, Genuine Parts And 3 Stocks To Watch Heading Into Tuesday2026-02-17
- Medtronic Wins FDA Nod for Spine System Aimed at Cutting Repeat Imaging2026-02-13
See today's live rating, score and targets
Members see the live hourly rating for MDT — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz